Skip to main content
Premium Trial:

Request an Annual Quote

10x Genomics: Bryan Roberts

10x Genomics said that on July 18, 2023, Bryan Roberts informed the company of his decision to resign from the board of directors, effective immediately.

Kimberly Popovits replaced Roberts as a member of the board's audit committee, effective July 19.

In a July 20 filing with the US Securities and Exchange Commission, 10x said Roberts' decision to resign was "due solely to professional time commitments and is not due to any disagreement with the company's management team, operations, financial statements, policies or procedures."

Roberts is a partner at Venrock and is involved with several other biotech companies, including Element Biosciences.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.